Gabanyur Capsule 300 mg (Pregabalin)

Adult dose

This medication is administered orally in divided doses, twice daily regardless of meals. 1. Neuropathic Pain 1) Peripheral Neuropathic Pain The starting dose is 150 mg per day, which may be increased to 300 mg per day within 3 to 7 days and may be further titrated to a maximum of 600 mg per day at intervals of 7 days if necessary. 2) Central Neuropathic Pain The starting dose is

Child dose

Administration is not recommended for children under 12 years of age and adolescents aged 12 to 17 due to insufficient safety and efficacy data.

This medication may increase the risk of suicidal thoughts and behaviors; therefore, if symptoms of depression or mood changes occur during treatment, the patient should inform their healthcare provider immediately. Patients with hypersensitivity to any component of this medication or with hereditary lactose intolerance should not take it. Diabetic patients should be careful as weight gain may necessitate adjustments to their blood glucose-regulating medications. If symptoms of angioedema occur, the medication should be discontinued immediately, and consultation with healthcare professionals is needed. In the elderly, there is a risk of falling due to dizziness or drowsiness, so special caution is required at the start of treatment. Blurred vision or changes in vision may occur, which can improve upon discontinuation of the medication. Abrupt discontinuation of this medication may result in withdrawal symptoms such as insomnia, headache, and anxiety; therefore, it should be tapered gradually under the guidance of a healthcare provider. Patients with a history of substance abuse should exercise caution due to the potential for misuse of this medication. Patients with reduced kidney function may require dose adjustments. Patients with heart conditions should use this medication cautiously as symptoms of congestive heart failure may worsen during treatment. Taking this medication with other central nervous system depressants or alcohol may increase the risk of drowsiness or respiratory suppression. Pregnant women or those planning to become pregnant should consult their healthcare provider before use due to the risk of fetal malformations in early pregnancy. Breastfeeding women are advised to either stop nursing or discontinue the medication as it may be passed into breast milk. Caution is needed when driving or operating machinery due to the risk of accidents from dizziness and drowsiness. In case of overdose, confusion, drowsiness, or seizures may occur, and immediate emergency treatment is required. Keep out of reach of children and do not transfer to another container for safety.

Serious side effects

Rash, severe swelling (edema), angioedema, facial swelling, swelling of the mouth and upper respiratory tract, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, mucosal pain in the mouth/eyes, Stevens-Johnson syndrome, toxic epidermal necrolysis, respiratory depression, shortness of breath or difficulty breathing, asthma attacks, cough + respiratory abnormalities with fever, jaundice (yellowing of skin or eyes), systemic reactions

Mild side effects

• Dizziness
• drowsiness
• confusion
• impaired coordination
• increased sensitivity
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly sealed container to protect it from air and moisture. A cool place between 15°C and 30°C is suitable for storage.

Appearance

A hard capsule with the upper part being reddish-brown and the lower part being white, containing a white or light yellow powder.

Package unit

30 capsules/bottle, 100 capsules/bottle